“ Evaluating the Antitumor Activity of Nintedanib by Solid Lipid Nanoparticle Drug Delivery System: In vitro and In vivo”, AJP, vol. 19, no. 04, Feb. 2026, doi: 10.22377/ajp.v19i04.7190.